Joi + Blokes telehealth platform specializing in diagnostic testing, personalized medicine, and hormone and menopause care. Recently, the company announced the publication of a peer-reviewed study in the Journal of Personalized Medicine demonstrating that testosterone replacement therapy in women is associated with significant improvements in energy, mood, cognitive function, and overall quality of life. The findings are based on an analysis of 330 women between the ages of 27 and 78, who received individualized testosterone therapy.
The results showed broad improvements across eight symptom domains, with 84% of participants reporting increased energy and nearly 90% reporting improved quality of life. Mood-related symptoms — such as depression and irritability — improved in over 65% of participants, and cognitive improvements like memory and concentration increased over time. The study also found favorable changes in key biomarkers, including reductions in triglycerides, improvements in hemoglobin linked to energy and oxygen delivery, and enhanced hormone balance as reflected by SHBG levels.
Image Credit: Joi + Blokes
What Makes This Trend Stand Out
- Women-centric Hormone Therapies
- Emerging demand for testosterone and tailored hormone regimens creates space for novel therapeutic formulations and delivery systems designed specifically for female physiology.
- Personalized Hormone Diagnostics
- Advances in individualized testing and biomarker-driven treatment planning point to platforms that integrate multi-marker panels and AI-driven interpretation to refine hormone replacement strategies.
- Telehealth Menopause Care
- Remote-first models that couple virtual consultations with at-home testing and continuous outcome tracking enable new care pathways focused on midlife and postmenopausal women.
Sectors Adopting This
- Telehealth Platforms
- Virtual clinics that specialize in longitudinal hormone management and real-world outcome collection could redefine patient engagement and treatment optimization.
- Diagnostics and Biomarkers
- Sensitive assays and point-of-care biomarker tools for sex-hormone profiles present opportunities to disrupt conventional lab-dependent workflows and accelerate personalized dosing.
- Pharmaceutical and Biotech
- Development of female-specific androgen formulations and delivery technologies may transform treatment paradigms by addressing safety, efficacy, and adherence unique to women.
